| Year |
Citation |
Score |
| 2017 |
Martineau X, Abed É, Martel-Pelletier J, Pelletier JP, Lajeunesse D. Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca2+ pathways in human osteoarthritis osteoblasts. Plos One. 12: e0180711. PMID 28777797 DOI: 10.1371/Journal.Pone.0180711 |
0.447 |
|
| 2017 |
Abed É, Delalandre A, Lajeunesse D. Beneficial effect of resveratrol on phenotypic features and activity of osteoarthritic osteoblasts. Arthritis Research & Therapy. 19: 151. PMID 28666466 DOI: 10.1186/S13075-017-1365-2 |
0.512 |
|
| 2017 |
Moussa M, Lajeunesse D, Hilal G, El Atat O, Haykal G, Serhal R, Chalhoub A, Khalil C, Alaaeddine N. Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human Osteoarthritic cartilage. Experimental Cell Research. PMID 28202394 DOI: 10.1016/J.Yexcr.2017.02.012 |
0.329 |
|
| 2015 |
Abed E, Bouvard B, Martineau X, Jouzeau JY, Reboul P, Lajeunesse D. Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity. Bone. 75: 111-9. PMID 25667190 DOI: 10.1016/J.Bone.2015.02.001 |
0.582 |
|
| 2015 |
Vasheghani F, Zhang Y, Li YH, Blati M, Fahmi H, Lussier B, Roughley P, Lagares D, Endisha H, Saffar B, Lajeunesse D, Marshall WK, Rampersaud YR, Mahomed NN, Gandhi R, et al. PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Annals of the Rheumatic Diseases. 74: 569-78. PMID 25573665 DOI: 10.1136/Annrheumdis-2014-205743 |
0.41 |
|
| 2015 |
Hu Y, Liu Y, Lajeunesse D, Mainard D, Jouzeau JY, Reboul P. Identification of two populations of osteoarthritic osteoblasts according to the 1,25[OH]₂ vitamin D₃ potency to stimulate osteocalcin. Bio-Medical Materials and Engineering. 25: 103-10. PMID 25538061 DOI: 10.3233/Bme-141230 |
0.352 |
|
| 2014 |
Bouvard B, Abed E, Yéléhé-Okouma M, Bianchi A, Mainard D, Netter P, Jouzeau JY, Lajeunesse D, Reboul P. Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts. Arthritis Research & Therapy. 16: 459. PMID 25312721 DOI: 10.1186/S13075-014-0459-3 |
0.515 |
|
| 2014 |
Abed É, Couchourel D, Delalandre A, Duval N, Pelletier JP, Martel-Pelletier J, Lajeunesse D. Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity. Bone. 59: 28-36. PMID 24184155 DOI: 10.1016/J.Bone.2013.10.020 |
0.464 |
|
| 2014 |
Abed É, Siwing V, Martineau X, Delalandre A, Lajeunesse D. Alterations of the non-canonical Wnt/PKC pathway in human osteoarthritis osteoblasts Osteoarthritis and Cartilage. 22: S159. DOI: 10.1016/J.Joca.2014.02.295 |
0.364 |
|
| 2014 |
Abed É, Delalandre A, Pelletier J, Martel-Pelletier J, Lajeunesse D. Resveratrol Regulates the Wnt/ß-catenin pathway in human osteoarthritis osteoblasts Osteoarthritis and Cartilage. 22: S158-S159. DOI: 10.1016/J.Joca.2014.02.294 |
0.36 |
|
| 2013 |
Pelletier JP, Kapoor M, Fahmi H, Lajeunesse D, Blesius A, Maillet J, Martel-Pelletier J. Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium. Annals of the Rheumatic Diseases. 72: 250-7. PMID 23065732 DOI: 10.1136/Annrheumdis-2012-201710 |
0.369 |
|
| 2013 |
Bouvard B, Lajeunesse D, Yelehe-Okouma M, Mainard D, Netter P, Abed E, Jouzeau J, Reboul P. FRI0048 Hypoxia in human osteoarthritic subchondral bone: a risk factor for leptin production by osteoblasts Annals of the Rheumatic Diseases. 72: A383.3-A384. DOI: 10.1136/Annrheumdis-2013-Eular.1175 |
0.523 |
|
| 2013 |
Abed É, Bouvard B, Delalandre A, Jouzeau J, Reboul P, Lajeunesse D. Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization Osteoarthritis and Cartilage. 21: S125-S126. DOI: 10.1016/J.Joca.2013.02.263 |
0.505 |
|
| 2012 |
Lajeunesse D, Chan TF, Delalandre A, Pelletier J, Martel-Pelletier J, Abed É. Abnormal osteogenesis in osteoarthritis: gone with the Wnt? Arthritis Research & Therapy. 14. DOI: 10.1186/Ar3574 |
0.341 |
|
| 2011 |
Abed É, Chan TF, Delalandre A, Martel-Pelletier J, Pelletier JP, Lajeunesse D. R-spondins are newly recognized players in osteoarthritis that regulate Wnt signaling in osteoblasts. Arthritis and Rheumatism. 63: 3865-75. PMID 22127703 DOI: 10.1002/Art.30625 |
0.437 |
|
| 2011 |
Chan TF, Couchourel D, Abed E, Delalandre A, Duval N, Lajeunesse D. Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 1399-410. PMID 21312269 DOI: 10.1002/Jbmr.358 |
0.413 |
|
| 2011 |
Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nature Reviews. Rheumatology. 7: 33-42. PMID 21119608 DOI: 10.1038/Nrrheum.2010.196 |
0.344 |
|
| 2011 |
Abed⁎ E, Delalandre A, Couchourel D, Lajeunesse D. Elevated endogenous sclerostin levels in osteoarthritis subchondral osteoblasts contribute to reduced Wnt/B-catenin signaling in these cells Bone. 48: S80. DOI: 10.1016/J.Bone.2011.03.100 |
0.353 |
|
| 2010 |
Mutabaruka MS, Aoulad Aissa M, Delalandre A, Lavigne M, Lajeunesse D. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Research & Therapy. 12: R20. PMID 20141628 DOI: 10.1186/Ar2925 |
0.507 |
|
| 2010 |
Kwan Tat S, Lajeunesse D, Pelletier JP, Martel-Pelletier J. Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Practice & Research. Clinical Rheumatology. 24: 51-70. PMID 20129200 DOI: 10.1016/J.Berh.2009.08.004 |
0.468 |
|
| 2010 |
Lajeunesse D. Is there a role for bone tissue in osteoarthritis? Therapy. 7: 649-659. DOI: 10.2217/thy.10.69 |
0.361 |
|
| 2009 |
Kwan Tat S, Amiable N, Pelletier JP, Boileau C, Lajeunesse D, Duval N, Martel-Pelletier J. Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. Rheumatology (Oxford, England). 48: 1482-90. PMID 19762475 DOI: 10.1093/Rheumatology/Kep300 |
0.506 |
|
| 2009 |
Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-Pelletier J, Pelletier JP, Lajeunesse D. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis and Rheumatism. 60: 1438-50. PMID 19404930 DOI: 10.1002/Art.24489 |
0.466 |
|
| 2009 |
Amiable N, Tat SK, Lajeunesse D, Duval N, Pelletier JP, Martel-Pelletier J, Boileau C. Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts. Bone. 44: 1143-50. PMID 19264156 DOI: 10.1016/J.Bone.2009.02.015 |
0.523 |
|
| 2009 |
Kwan-Tat S, Amiable N, Pelletier J, Boileau C, Lajeunesse D, Lavigne M, Martel-Pelletier J. 238 MODULATION OF OSTEOPROTEGERIN, RANK, RANKL BY HUMAN CHONDROCYTES AND THEIR IMPLICATION IN OSTEOARTHRITIS Osteoarthritis and Cartilage. 17: S133. DOI: 10.1016/S1063-4584(09)60260-0 |
0.345 |
|
| 2009 |
Chan T, Couchourel D, Delalandre A, Lajeunesse D. 056 ALTERED WNT/b-CATENIN SIGNALING IN HUMAN OSTEOARTHRITIC SUBCHONDRAL OSTEOBLASTS IS DUE TO DICKKOPF-2 (DKK2) AND PROSTAGLANDIN E2 (PGE2) LEVELS Osteoarthritis and Cartilage. 17: S38. DOI: 10.1016/S1063-4584(09)60079-0 |
0.354 |
|
| 2009 |
Moreau M, Rialland P, Pelletier J, Martel-Pelletier J, Lajeunesse D, Boileau C, Caron J, Beauchamp G, Gauvin D, Troncy E. 004 TILUDRONATE IN AN EXPERIMENTAL DOG MODEL OF OSTEOARTHRITIS: BONE ANTI-RESORPTIVE ACTIVITY AND RELATED FUNCTIONAL IMPROVEMENT Osteoarthritis and Cartilage. 17: S10-S11. DOI: 10.1016/S1063-4584(09)60027-3 |
0.421 |
|
| 2009 |
Lajeunesse D. I-12 ROLE OF BONE IN THE DEVELOPMENT AND PROGRESSION OF OSTEOARTHRITIS Osteoarthritis and Cartilage. 17: S5. DOI: 10.1016/S1063-4584(09)60017-0 |
0.375 |
|
| 2009 |
Tat SK, Pelletier JP, Lajeunesse D, Fahmi H, Duval N, Martel-Pelletier J. Corrigendum to "Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: Influence of osteotropic factors" [Bone 43 (2008) 284-291] (DOI:10.1016/j.bone.2008.04.006) Bone. 44: 387. DOI: 10.1016/J.Bone.2008.10.043 |
0.467 |
|
| 2008 |
Kwan Tat S, Pelletier JP, Amiable N, Boileau C, Lajeunesse D, Duval N, Martel-Pelletier J. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Arthritis and Rheumatism. 58: 3820-30. PMID 19035475 DOI: 10.1002/Art.24029 |
0.493 |
|
| 2008 |
Fernandes JC, Shi Q, Benderdour M, Lajeunesse D, Lavigne P. An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro. Journal of Bone and Mineral Metabolism. 26: 543-50. PMID 18979153 DOI: 10.1007/S00774-008-0866-0 |
0.425 |
|
| 2008 |
Tat SK, Pelletier JP, Lajeunesse D, Fahmi H, Duval N, Martel-Pelletier J. Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors. Bone. 43: 284-91. PMID 18539107 DOI: 10.1016/J.Bone.2008.04.006 |
0.515 |
|
| 2007 |
Tat SK, Pelletier JP, Vergés J, Lajeunesse D, Montell E, Fahmi H, Lavigne M, Martel-Pelletier J. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study. Arthritis Research & Therapy. 9: R117. PMID 17996099 DOI: 10.1186/Ar2325 |
0.493 |
|
| 2007 |
Lajeunesse D, Mutabaruka M, Aoulab-Aissa M, Delalandre A. Altered expression and production of leptin is responsible for abnormal cell markers in subchondral osteoblasts from osteoarthritic patients Arthritis Research & Therapy. 9: P36. DOI: 10.1186/Ar2262 |
0.347 |
|
| 2007 |
Chouchourel D, Bariteau G, Delalandre A, Lajeunesse D. Abnormal collagen type 1 production in subchondral osteoarthritic osteoblasts is responsible in part for altered mineralization in these cells Arthritis Research & Therapy. 9: P35. DOI: 10.1186/Ar2261 |
0.363 |
|
| 2007 |
Kwan Tat S, Pelletier J, Lajeunesse D, Fahmi H, Duval N, Martel-Pelletier J. 13 THE REMODELLING PROCESS OF THE SUBCHONDRAL BONE DURING HUMAN OSTEOARTHRITIS IS CLOSELY DEPENDENT ON RANKL MODULATION Osteoarthritis and Cartilage. 15: C21-C22. DOI: 10.1016/S1063-4584(07)61649-5 |
0.467 |
|
| 2007 |
Lajeunesse D. DOES SUBCHONDRAL BONE TISSUE REMODELING OR CELL FUNCTION PLAY A ROLE IN ARTICULAR CARTILAGE LOSS IN OSTEOARTHRITIS? Osteoarthritis and Cartilage. 15: C3. DOI: 10.1016/S1063-4584(07)61609-4 |
0.372 |
|
| 2007 |
Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier JP. The Role of Subchondral Bone in Osteoarthritis Osteoarthritis: a Companion to Rheumatology. 15-32. DOI: 10.1016/B978-0-323-03929-1.50007-0 |
0.391 |
|
| 2006 |
Maxis K, Delalandre A, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein. Arthritis Research & Therapy. 8: R181. PMID 17156456 DOI: 10.1186/Ar2092 |
0.486 |
|
| 2006 |
Massicotte F, Aubry I, Martel-Pelletier J, Pelletier JP, Fernandes J, Lajeunesse D. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Research & Therapy. 8: R177. PMID 17129375 DOI: 10.1186/Ar2087 |
0.767 |
|
| 2006 |
Martel-Pelletier J, Lajeunesse D, Fahmi H, Tardif G, Pelletier JP. New thoughts on the pathophysiology of osteoarthritis: one more step toward new therapeutic targets. Current Rheumatology Reports. 8: 30-6. PMID 16515762 DOI: 10.1007/S11926-006-0022-6 |
0.44 |
|
| 2006 |
Massicotte F, Fernandes JC, Martel-Pelletier J, Pelletier JP, Lajeunesse D. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone. 38: 333-41. PMID 16257278 DOI: 10.1016/J.Bone.2005.09.007 |
0.788 |
|
| 2005 |
Pelletier JP, Boileau C, Boily M, Brunet J, Mineau F, Geng C, Reboul P, Laufer S, Lajeunesse D, Martel-Pelletier J. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Research & Therapy. 7: R1091-102. PMID 16207326 DOI: 10.1186/Ar1788 |
0.395 |
|
| 2005 |
Lavigne P, Benderdour M, Shi Q, Lajeunesse D, Fernandes JC. Involvement of ICAM-1 in bone metabolism: a potential target in the treatment of bone diseases? Expert Opinion On Biological Therapy. 5: 313-20. PMID 15833069 DOI: 10.1517/14712598.5.3.313 |
0.453 |
|
| 2005 |
Lavigne P, Benderdour M, Lajeunesse D, Reboul P, Shi Q, Pelletier JP, Martel-Pelletier J, Fernandes JC. Subchondral and trabecular bone metabolism regulation in canine experimental knee osteoarthritis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 13: 310-7. PMID 15780644 DOI: 10.1016/J.Joca.2004.12.015 |
0.469 |
|
| 2004 |
Lavigne P, Benderdour M, Lajeunesse D, Shi Q, Fernandes JC. Expression of ICAM-1 by osteoblasts in healthy individuals and in patients suffering from osteoarthritis and osteoporosis. Bone. 35: 463-70. PMID 15268898 DOI: 10.1016/J.Bone.2003.12.030 |
0.458 |
|
| 2004 |
Pelletier JP, Boileau C, Brunet J, Boily M, Lajeunesse D, Reboul P, Laufer S, Martel-Pelletier J. The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K. Bone. 34: 527-38. PMID 15003800 DOI: 10.1016/J.Bone.2003.11.021 |
0.441 |
|
| 2004 |
Lavigne P, Shi Q, Lajeunesse D, Dehnade F, Fernandes JC. Metabolic activity of osteoblasts retrieved from osteoarthritic patients after stimulation with mediators involved in periprosthetic loosening. Bone. 34: 478-86. PMID 15003795 DOI: 10.1016/J.Bone.2003.10.006 |
0.329 |
|
| 2004 |
Lajeunesse D. The role of bone in the treatment of osteoarthritis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 12: S34-8. PMID 14698639 DOI: 10.1016/J.Joca.2003.09.013 |
0.56 |
|
| 2004 |
Lajeunesse D, Martel-Pelletier J, Fernandes JC, Laufer S, Pelletier JP. Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis. Annals of the Rheumatic Diseases. 63: 78-83. PMID 14672896 DOI: 10.1136/ard.2002.003624 |
0.331 |
|
| 2003 |
Lajeunesse D, Massicotte F, Pelletier JP, Martel-Pelletier J. Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander. Modern Rheumatology / the Japan Rheumatism Association. 13: 7-14. PMID 24387110 DOI: 10.3109/S101650300001 |
0.777 |
|
| 2003 |
Lajeunesse D, Delalandre A, Martel-Pelletier J, Pelletier JP. Hyaluronic acid reverses the abnormal synthetic activity of human osteoarthritic subchondral bone osteoblasts. Bone. 33: 703-10. PMID 14555276 DOI: 10.1016/S8756-3282(03)00206-0 |
0.504 |
|
| 2003 |
Lajeunesse D, Reboul P. Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling. Current Opinion in Rheumatology. 15: 628-33. PMID 12960492 DOI: 10.1097/00002281-200309000-00018 |
0.491 |
|
| 2003 |
Guévremont M, Martel-Pelletier J, Massicotte F, Tardif G, Pelletier JP, Ranger P, Lajeunesse D, Reboul P. Human adult chondrocytes express hepatocyte growth factor (HGF) isoforms but not HgF: potential implication of osteoblasts on the presence of HGF in cartilage. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 1073-81. PMID 12817761 DOI: 10.1359/Jbmr.2003.18.6.1073 |
0.792 |
|
| 2003 |
Reboul P, Guévremont M, Martel-Pelletier J, Massicotte F, Ranger P, Pelletier J, Lajeunesse D. Hepatocyte growth factor in osteoarthritis: when bone and cartilage decide to have a chat Arthritis Research & Therapy. 5: 162-162. DOI: 10.1186/Ar963 |
0.791 |
|
| 2003 |
Lajeunesse D, Massicotte F, Aubry I, Martel-Pelletier J, Pelletier J. Arthritis Research & Therapy. 5: 63. DOI: 10.1186/Ar864 |
0.771 |
|
| 2002 |
Dubois SG, Ruchon AF, Delalandre A, Boileau G, Lajeunesse D. Role of abnormal neutral endopeptidase-like activities in Hyp mouse bone cells in renal phosphate transport. American Journal of Physiology. Cell Physiology. 283: C1414-21. PMID 12372802 DOI: 10.1152/Ajpcell.00135.2002 |
0.626 |
|
| 2002 |
Xie W, Méchin MC, Dubois SG, Lajeunesse D, van de Werve G. Up-regulation of liver glucose-6-phosphatase in x-linked hypophosphatemic mice. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et MéTabolisme. 34: 288-92. PMID 12173068 DOI: 10.1055/S-2002-33256 |
0.508 |
|
| 2002 |
Shi Q, Lajeunesse D, Reboul P, Martel-Pelletier J, Pelletier JP, Dehnade F, Fernandes JC. Metabolic activity of osteoblasts from periprosthetic trabecular bone in failed total hip arthroplasties and osteoarthritis as markers of osteolysis and loosening. The Journal of Rheumatology. 29: 1437-45. PMID 12136903 |
0.38 |
|
| 2002 |
Paredes Y, Massicotte F, Pelletier JP, Martel-Pelletier J, Laufer S, Lajeunesse D. Study of the role of leukotriene B()4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition. Arthritis and Rheumatism. 46: 1804-12. PMID 12124864 DOI: 10.1002/Art.10357 |
0.732 |
|
| 2002 |
Massicotte F, Lajeunesse D, Benderdour M, Pelletier JP, Hilal G, Duval N, Martel-Pelletier J. Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 10: 491-500. PMID 12056853 DOI: 10.1053/Joca.2002.0528 |
0.701 |
|
| 2001 |
Hilal G, Massicotte F, Martel-Pelletier J, Fernandes JC, Pelletier JP, Lajeunesse D. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 16: 713-21. PMID 11315999 DOI: 10.1359/Jbmr.2001.16.4.713 |
0.773 |
|
| 2000 |
Lajeunesse D, Delalandre A, Guggino SE. Thiazide diuretics affect osteocalcin production in human osteoblasts at the transcription level without affecting vitamin D3 receptors. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 15: 894-901. PMID 10804019 DOI: 10.1359/Jbmr.2000.15.5.894 |
0.44 |
|
| 1999 |
Hilal G, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts. Arthritis and Rheumatism. 42: 2112-22. PMID 10524682 DOI: 10.1002/1529-0131(199910)42:10<2112::Aid-Anr11>3.0.Co;2-N |
0.551 |
|
| 1999 |
Pelletier JP, Lajeunesse D, Hilal G, Jovanovic D, Fernandes JC, Martel-Pelletier J. Carprofen reduces the structural changes and the abnormal subchondral bone metabolism of experimental osteoarthritis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 7: 327-8. PMID 10329317 DOI: 10.1053/Joca.1998.0183 |
0.404 |
|
| 1999 |
Lajeunesse D, Hilal G, Pelletier JP, Martel-Pelletier J. Subchondral bone morphological and biochemical alterations in osteoarthritis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 7: 321-2. PMID 10329314 DOI: 10.1053/Joca.1998.0180 |
0.479 |
|
| 1998 |
Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis and Rheumatism. 41: 891-9. PMID 9588742 DOI: 10.1002/1529-0131(199805)41:5<891::Aid-Art17>3.0.Co;2-X |
0.516 |
|
| 1998 |
Martel-Pelletier J, Di Battista JA, Lajeunesse D, Pelletier JP. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 47: 90-100. PMID 9562333 DOI: 10.1007/S000110050288 |
0.556 |
|
| 1996 |
Lajeunesse D, Busque L, Ménard P, Brunette MG, Bonny Y. Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. Correction of the phenotype after bone marrow transplant. The Journal of Clinical Investigation. 98: 1835-42. PMID 8878435 DOI: 10.1172/JCI118984 |
0.361 |
|
| 1994 |
Lajeunesse D. Effect of 17 beta-estradiol on the human osteosarcoma cell line MG-63. Bone and Mineral. 24: 1-16. PMID 8186730 DOI: 10.1016/S0169-6009(08)80126-2 |
0.321 |
|
| 1991 |
Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone and Mineral. 14: 237-50. PMID 1657256 DOI: 10.1016/0169-6009(91)90025-U |
0.393 |
|
| 1990 |
Lajeunesse D, Frondoza C, Schoffield B, Sacktor B. Osteocalcin secretion by the human osteosarcoma cell line MG-63. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 5: 915-22. PMID 2177953 DOI: 10.1002/Jbmr.5650050904 |
0.368 |
|
| 1989 |
Guggino SE, Lajeunesse D, Wagner JA, Snyder SH. Bone remodeling signaled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel. Proceedings of the National Academy of Sciences of the United States of America. 86: 2957-60. PMID 2468165 DOI: 10.1073/Pnas.86.8.2957 |
0.398 |
|
| Show low-probability matches. |